Excitotoxic SLC7A11 Expression Is a Marker of Poor Glioblastoma Survival and a Potential Therapeutic Target
- PMID: 26584321
- DOI: 10.1227/01.neu.0000473809.76102.ee
Excitotoxic SLC7A11 Expression Is a Marker of Poor Glioblastoma Survival and a Potential Therapeutic Target
Comment on
-
SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma.Sci Transl Med. 2015 May 27;7(289):289ra86. doi: 10.1126/scitranslmed.aaa8103. Sci Transl Med. 2015. PMID: 26019222 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical